Detailed lists of materials and instrumentation,
cloning, production, and purification of KRAS and related proteins
(Figures S1 and S2 ), Alexa680 conjugations,
and γ-GTP-Eu3+ synthesis (Figures S3–S5 ) are presented in the Supporting Information (SI) . In addition, detailed protocols for KRAS/RAF-RBD
interaction concentration optimization, KRAS enzymatic glycosylation,
and data analysis are presented in theSI . All presented assays were performed in triplicate unless otherwise
indicated.
We selected 50 and 200 nM KRAS for further nucleotide
association and protein–protein interaction monitoring. Assays
were performed using protocol 1 in a 15 μL final volume. First,
we assayed two known KRAS-inhibiting designed ankyrin repeat proteins
(DARPins) to monitor their functional concentrations.42 (link) DARPins (K27 and K55) were titrated up to 20 μM in
a reaction with KRAS (200 nM), Eu3+-GTP (25 nM), MG (24
μM), and SOScat (10 nM). Signals were monitored 15
min after SOScat addition, following RBD-Alexa680 (25 nM)
addition and a second measurement after 15 min. DARPins K27 and K55
were thereafter used in single selected concentrations. KRAS was incubated
with K27 (500 nM) and K55 (5 μM) for 10 min in a 7 μL
volume. Detection solution (6 μL) containing Eu3+-GTP (25 nM), MG (24 μM), and RBD-Alexa680 (25 nM) was added,
and signals were monitored after 5 min at 615 and 730 nm. Nucleotide
association and KRAS/RAF-RBD interaction were launched by 10 nM SOScat (2 μL), and signals were monitored during a 60 min
incubation at RT. Thereafter, nucleotide association and KRAS/RAF-RBD
interaction were separated. Again, KRAS was incubated with K27 and
K55 for 10 min. A QRET detection solution (4 μL) containing
Eu3+-GTP (25 nM) and MG (24 μM) was added, and signals
were monitored. After 10 nM SOScat (2 μL) addition,
signals were kinetically monitored for 1000 s, before 25 nM of RBD-Alexa680
(2 μL) was added, and signal monitoring was continued for 20
min.
cloning, production, and purification of KRAS and related proteins
(
and γ-GTP-Eu3+ synthesis (
interaction concentration optimization, KRAS enzymatic glycosylation,
and data analysis are presented in the
indicated.
We selected 50 and 200 nM KRAS for further nucleotide
association and protein–protein interaction monitoring. Assays
were performed using protocol 1 in a 15 μL final volume. First,
we assayed two known KRAS-inhibiting designed ankyrin repeat proteins
(DARPins) to monitor their functional concentrations.42 (link) DARPins (K27 and K55) were titrated up to 20 μM in
a reaction with KRAS (200 nM), Eu3+-GTP (25 nM), MG (24
μM), and SOScat (10 nM). Signals were monitored 15
min after SOScat addition, following RBD-Alexa680 (25 nM)
addition and a second measurement after 15 min. DARPins K27 and K55
were thereafter used in single selected concentrations. KRAS was incubated
with K27 (500 nM) and K55 (5 μM) for 10 min in a 7 μL
volume. Detection solution (6 μL) containing Eu3+-GTP (25 nM), MG (24 μM), and RBD-Alexa680 (25 nM) was added,
and signals were monitored after 5 min at 615 and 730 nm. Nucleotide
association and KRAS/RAF-RBD interaction were launched by 10 nM SOScat (2 μL), and signals were monitored during a 60 min
incubation at RT. Thereafter, nucleotide association and KRAS/RAF-RBD
interaction were separated. Again, KRAS was incubated with K27 and
K55 for 10 min. A QRET detection solution (4 μL) containing
Eu3+-GTP (25 nM) and MG (24 μM) was added, and signals
were monitored. After 10 nM SOScat (2 μL) addition,
signals were kinetically monitored for 1000 s, before 25 nM of RBD-Alexa680
(2 μL) was added, and signal monitoring was continued for 20
min.